Accovion names a new CEO; Cromos reaches into Israel;

> Germany's Accovion has named Andree Beckerling as its next CEO, replacing Martin Schröder, who has helmed the company since it spun off of Aventis 8 years ago. News

> European CRO Cromos Pharma has expanded its footprint to include Israel, where it believes the market for clinical research is growing. Story

> WuXi PharmaTech ($WX) is poised to outperform its financial guidance for 2013, the company said, expecting to beat its earnings projections when it releases full-year financials in March. Article

Free Webinar

From Patient Adherence to Manufacturing Ease - Why Softgels Make Sense for Rx

Join Thermo Fisher Scientific’s upcoming webinar to learn why softgels offer numerous benefits for Rx drug development, including enhanced bioavailability, patient compliance and easy scale-up. Register Today.

Suggested Articles

Galapagos is selling off its contract research organization Fidelta for $37 million to Polish life science company Selvita.

Decentralized study company Medable has raised a large $91 million funding round as it continues to ramp up the deals in 2020.

Biotech IPOs are up over 40% year-to-date, but today’s markets have rewritten the rules for going public. Find out the new best practices for IPOs.